3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
12
Gastrointestinal
6
Myeloid
5
Lymphoid
5
Genitourinary
5
CNS
5
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Lung Neoplasms
26
Carcinoma, Non-Small-Cell Lung
15
Small Cell Lung Carcinoma
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Melanoma
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pulmonary Disease, Chronic Obstructive
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberculosis
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Thoracic Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdomyosarcoma
1
Precancerous Conditions
1
Pneumonia
1
Pleural Effusion, Malignant
1
Interventions
pembrolizumab
11
Cyclophosphamide
8
Gemcitabine
7
Cisplatin
7
tislelizumab
5
Docetaxel
5
Nivolumab
4
Injections
4
spartalizumab
3
regorafenib
3
Trastuzumab
3
Oncolytic Virotherapy
3
Irinotecan
3
Filgrastim
3
Drug Therapy
3
Doxorubicin
3
Carboplatin
3
Bortezomib
3
tazemetostat
2
pazopanib
2
liposomal doxorubicin
2
ganitumab
2
conatumumab
2
belinostat
2
Temozolomide
2
Taxes
2
Tamoxifen
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
X-Rays
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled